200 related articles for article (PubMed ID: 8751720)
1. Regulation of tumor growth and metastasis by thrombospondin-1.
Roberts DD
FASEB J; 1996 Aug; 10(10):1183-91. PubMed ID: 8751720
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells.
Guo N; Krutzsch HC; Inman JK; Roberts DD
Cancer Res; 1997 May; 57(9):1735-42. PubMed ID: 9135017
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells.
Castle VP; Dixit VM; Polverini PJ
Lab Invest; 1997 Jul; 77(1):51-61. PubMed ID: 9251678
[TBL] [Abstract][Full Text] [Related]
4. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.
Weinstat-Saslow DL; Zabrenetzky VS; VanHoutte K; Frazier WA; Roberts DD; Steeg PS
Cancer Res; 1994 Dec; 54(24):6504-11. PubMed ID: 7527299
[TBL] [Abstract][Full Text] [Related]
5. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
6. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia.
Bertin N; Clezardin P; Kubiak R; Frappart L
Cancer Res; 1997 Feb; 57(3):396-9. PubMed ID: 9012463
[TBL] [Abstract][Full Text] [Related]
8. Stromal thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas.
Oshiba G; Kijima H; Himeno S; Kenmochi T; Kise Y; Tanaka H; Nishi T; Chino O; Shimada H; Machimura T; Tsuchida T; Nakamura M; Ueyama Y; Tanaka M; Tajima T; Makuuchi H
Anticancer Res; 1999; 19(5C):4375-8. PubMed ID: 10650779
[TBL] [Abstract][Full Text] [Related]
9. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
[TBL] [Abstract][Full Text] [Related]
10. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides.
Wilson KE; Li Z; Kara M; Gardner KL; Roberts DD
J Immunol; 1999 Oct; 163(7):3621-8. PubMed ID: 10490955
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of novel thrombospondin 1 type I repeat fusion proteins.
Qabar AN; Bullock J; Matej L; Polverini P
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):147-53. PubMed ID: 10657251
[TBL] [Abstract][Full Text] [Related]
12. The role of thrombospondin-1 in tumor progression and angiogenesis.
Tuszynski GP; Nicosia RF
Bioessays; 1996 Jan; 18(1):71-6. PubMed ID: 8593167
[TBL] [Abstract][Full Text] [Related]
13. Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells.
Liska DJ; Hawkins R; Wikstrom K; Bornstein P
J Cell Physiol; 1994 Mar; 158(3):495-505. PubMed ID: 8126073
[TBL] [Abstract][Full Text] [Related]
14. Opposite regulation of thrombospondin-1 and corticotropin-induced secreted protein/thrombospondin-2 expression by adrenocorticotropic hormone in adrenocortical cells.
Lafeuillade B; Pellerin S; Keramidas M; Danik M; Chambaz EM; Feige JJ
J Cell Physiol; 1996 Apr; 167(1):164-72. PubMed ID: 8698834
[TBL] [Abstract][Full Text] [Related]
15. In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment.
Quesada AJ; Nelius T; Yap R; Zaichuk TA; Alfranca A; Filleur S; Volpert OV; Redondo JM
Cell Death Differ; 2005 Jun; 12(6):649-58. PubMed ID: 15818399
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth.
Sid B; Sartelet H; Bellon G; El Btaouri H; Rath G; Delorme N; Haye B; Martiny L
Crit Rev Oncol Hematol; 2004 Mar; 49(3):245-58. PubMed ID: 15036264
[TBL] [Abstract][Full Text] [Related]
17. Expression and role of thrombospondin-1 in colorectal cancer.
Miyanaga K; Kato Y; Nakamura T; Matsumura M; Amaya H; Horiuchi T; Chiba Y; Tanaka K
Anticancer Res; 2002; 22(6C):3941-8. PubMed ID: 12553016
[TBL] [Abstract][Full Text] [Related]
18. BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors.
Tsuchida R; Osawa T; Wang F; Nishii R; Das B; Tsuchida S; Muramatsu M; Takahashi T; Inoue T; Wada Y; Minami T; Yuasa Y; Shibuya M
Oncogene; 2014 Jul; 33(29):3803-11. PubMed ID: 24013228
[TBL] [Abstract][Full Text] [Related]
19. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.
Filleur S; Volpert OV; Degeorges A; Voland C; Reiher F; Clézardin P; Bouck N; Cabon F
Genes Dev; 2001 Jun; 15(11):1373-82. PubMed ID: 11390357
[TBL] [Abstract][Full Text] [Related]
20. Androgen and fibroblast growth factor 8 (FGF8) downregulation of thrombospondin 1 (TSP1) in mouse breast cancer cells.
Mattila MM; Tarkkonen KM; Seppänen JA; Ruohola JK; Valve EM; Härkönen PL
Mol Cell Endocrinol; 2006 Jul; 253(1-2):36-43. PubMed ID: 16723184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
